Skip to content

A multifactorial study of moxibustion timing X application interval in a unit of thermal moxibustion for perennial allergic rhinitis

A multifactorial study of moxibustion timing X application interval in a unit of thermal moxibustion for perennial allergic rhinitis

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069348
Enrollment
Unknown
Registered
2023-03-14
Start date
2023-03-15
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perennial allergic rhinitis

Interventions

Group A:Apply moxibustion for 15min, 1 time/d
Group B:Apply moxibustion for 15min, once every other day
Group C:Apply moxibustion for 40min, once every other day
Group D:Apply moxibustion for 40min, 1 time/d

Sponsors

Affiliated Hospital of Jiangxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The diagnostic criteria for Western medicine are based on the "Guidelines for the Diagnosis and Treatment of Allergic Rhinitis" issued by the Chinese Medical Association, while the diagnostic criteria for Chinese medicine are based on the diagnostic criteria for "congested nose" in the "Guidelines for the Treatment of Common Diseases of Otolaryngology in Chinese Medicine" issued by the Chinese Academy of Traditional Chinese Medicine; 2. Mild intermittent and mild persistent allergic rhinitis; 3. Age 18 to 60 years old, regardless of gender; 4. Voluntarily participate in this clinical observation and sign the informed consent form; 5. Ability to comply with the doctor's treatment schedule and to cooperate with the doctor's treatment and follow-up visits; 6. Patients who are clearly conscious, can express the moxibustion sensation correctly and can produce moxibustion sensation in the upper Indo acupoint area.

Exclusion criteria

Exclusion criteria: 1. Persons with combined serious cardiovascular, hepatic, renal and haematopoietic diseases; 2. Other nasal problems such as chronic rhinitis, sinusitis, nasal polyps, deviated nasal septum, etc.; 3. Psychiatric patients, pregnant or breastfeeding women; 4. Patients with upper respiratory diseases such as asthma and bronchitis; 5. People who are dizzy from needles or moxibustion or who reject it.

Design outcomes

Primary

MeasureTime frame
Signs and Symptoms Rating Scale;

Secondary

MeasureTime frame
Nasal Symptoms Summary Table;Rhinitis accompanying symptoms scale;Rhinoconjunctivitis-related quality of life scale;Serum-specific IgE;

Countries

China

Contacts

Public ContactLingling Xu

Affiliated Hospital of Jiangxi University of Chinese Medicine

314037897@qq.com+86 181 7086 7570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026